NCT01469676View on ClinicalTrials.gov

Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

October 31, 2010

Conditions
Systemic Inflammatory Response Syndrome (SIRS)Leukocyte DisordersComplications Due to Coronary Artery Bypass Graft
Interventions
DEVICE

Filtering group LG-6, Pall Biomedical Products

In Filtering group, a Leukocyte filter (LG-6, Pall Biomedical Products) was placed on the CPB arterial line circuit, trying to filter the white blood cells.

All Listed Sponsors
collaborator

InCor Heart Institute

OTHER

collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Sao Paulo

OTHER

NCT01469676 - Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function | Biotech Hunter | Biotech Hunter